Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fennec Pharmaceuticals Inc.

8.43
+0.53006.71%
Volume:120.96K
Turnover:1.01M
Market Cap:232.83M
PE:-16.01
High:8.72
Open:7.99
Low:7.98
Close:7.90
Loading ...

Fennec Pharmaceuticals Director Rosty Raykov Reports Disposal of Common Shares

Reuters
·
07 Jun

Fennec Pharmaceuticals Inc. Conducted Annual Shareholder Meeting

Reuters
·
04 Jun

Fennec Pharmaceuticals Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Dow Jones
·
20 May

CEO Jeffrey S. Hackman Acquires Common Shares of Fennec Pharmaceuticals Inc

Reuters
·
20 May

Fennec Pharmaceuticals Is Maintained at Buy by Craig-Hallum

Dow Jones
·
15 May

BUZZ-Fennec Pharma rises after Q1 sales beat

Reuters
·
13 May

Fennec Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 May

Fennec Pharmaceuticals Q1 Product Sales USD 8.8 Million

Reuters
·
13 May

Fennec Pharmaceuticals Q1 EPS $(0.04) Beats $(0.09) Estimate, Sales $8.75M Beat $8.18M Estimate

Benzinga
·
13 May

Fennec Pharmaceuticals Reports 18% Increase in Q1 2025 Net Product Sales to $8.8 Million

Reuters
·
13 May

Fennec Pharmaceuticals Inc - Q1 2025 Revenues up 18% to $8.8 Million

THOMSON REUTERS
·
13 May

Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

THOMSON REUTERS
·
13 May

Fennec Pharmaceuticals Q1 Basic EPS USD -0.04

THOMSON REUTERS
·
13 May

Fennec Pharmaceuticals Inc expected to post a loss of 9 cents a share - Earnings Preview

Reuters
·
09 May

Immunocore (IMCR) Moves 6.0% Higher: Will This Strength Last?

Zacks
·
21 Mar

Fennec Pharmaceuticals Full Year 2024 Earnings: US$0.003 loss per share (vs US$0.60 loss in FY 2023)

Simply Wall St.
·
11 Mar

Fennec Pharmaceuticals Price Target Maintained With a $13.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Mar

Fennec Pharmaceuticals Inc (FENC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com
·
11 Mar

Q4 2024 Fennec Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents
·
11 Mar

Fennec Pharmaceuticals Shares Down After 4Q Results

Dow Jones
·
11 Mar